Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

This study has suspended participant recruitment.
(researchers delay)
Sponsor:
Information provided by:
King Faisal University
ClinicalTrials.gov Identifier:
NCT01132417
First received: September 19, 2009
Last updated: June 21, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: July 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)